Judge strikes down Obamacare coverage of preventive care for cancers, diabetes, HIV and other conditions

Judge strikes down Obamacare coverage of preventive care for cancers, diabetes, HIV and other conditions


A consultant analyzing a mammogram.

Rui Vieira | PA Wire | Getty Images

A federal judge on Thursday struck down an Obamacare mandate that required most private health insurance plans to cover preventive care such as certain cancer screenings and HIV prevention drugs.

These services included screenings for breast, cervical and lung cancers; tests for sexually transmitted infections; as well as coverage of drugs that prevent HIV infection in high risk populations, called pre-exposure prophylaxis or PrEP.

You can find the full list of covered preventive services the judge struck down here.

Judge Reed O’Connor in U.S. Northern District of Texas struck down those coverage requirements and blocked the federal government from enforcing them. The Biden administration is likely to appeal the ruling.

The Department of Health and Human Services did not immediately respond to a request to comment.

The Affordable Care Act mandated free coverage of health services recommended by an independent panel of experts called the Preventive Services Task Force. O’Connor said that these coverage requirements are unconstitutional because the task force’s members were not nominated by the president and confirmed by the Senate, according to his opinion.

Two Christian businesses and several individuals sued the federal government in 2020, arguing that the preventive care mandate violates their religious freedom because it includes coverage of PrEP drugs that prevent HIV infection.

They claimed the mandate violated their religious beliefs by “making them complicit in facilitating homosexual behavior, drug use, and sexual activity outside of marriage between one man and one woman,” according to court documents.

They had also sought to overturn the federal mandate that requires Obamacare compliant plans to cover birth control with no out-of-pocket costs. O’Connor ruled against those claims and kept the contraception mandate in place.

This is a developing story. Please check back for updates.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says
Health

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency’s Commissioner Marty Makary told CNBC on Friday.  The FDA in June announced a national priority voucher plan that aims to cut drug review times to one-to-two months for companies it says are […]

Read More
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Health

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

The Hers website arranged on a laptop in New York, US, on Wednesday, Feb. 12, 2025. Gabby Jones | Bloomberg | Getty Images Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk‘s patent on its branded drugs Ozempic and Wegovy is set to expire in January. “Canada is […]

Read More
Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’
Health

Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’

U.S. President Donald Trump speaks next to Defense Secretary Pete Hegseth during a cabinet meeting at the White House in Washington, D.C., U.S., July 8, 2025. Kevin Lamarque | Reuters President Donald Trump on Tuesday threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S. “very soon.”  “They’re going to be tariffs […]

Read More